	US 11,806,380 B2
	Method and composition for preventing and treating COVID-19 and long COVID
Mei-Nan Tuan, Taipei (TW); Hien Ly Doan, Taipei (TW); Zi-Yi Huang, Kaohsiung (TW); Chia-Yin Lee, Douliu (TW); and Thuc Anh Nguyen, Taipei (TW)
Assigned to GLOBAL PREVENTIVE MEDICINE BIOTECH COMPANY LIMITED, New Taipei (TW)
Filed by GLOBAL PREVENTIVE MEDICINE BIOTECH COMPANY LIMITED, New Taipei (TW)
Filed on Jun. 7, 2022, as Appl. No. 17/834,215.
Claims priority of provisional application 63/277,774, filed on Nov. 10, 2021.
Claims priority of provisional application 63/197,701, filed on Jun. 7, 2021.
Prior Publication US 2022/0387541 A1, Dec. 8, 2022
Int. Cl. A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 36/185 (2006.01); A61K 36/63 (2006.01); A61K 36/28 (2006.01); A61P 31/14 (2006.01); A61K 36/48 (2006.01); A61K 31/353 (2006.01); A61K 31/7048 (2006.01); A61K 31/352 (2006.01); A61K 31/05 (2006.01); A61K 31/716 (2006.01)

CPC A61K 36/82 (2013.01) [A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/7048 (2013.01); A61K 31/716 (2013.01); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61K 36/48 (2013.01); A61K 36/63 (2013.01); A61K 36/87 (2013.01); A61P 31/14 (2018.01)]

4 Claims

1. A capsule consisting essentially of a grape seed extract, an acerola cherry extract, an olive leaf extract, a marigold extract, a green tea extract, a pomegranate extract, a yeast beta-glucan and a soybean extract.